Skip to Content

Introducing the QbD1200+ Total Organic Carbon Analyzer by Beckman Coulter Life Sciences

Simplified Operation and Cost-Effective Solution Offered by a New Instrument

In the realm of laboratory automation and advancement, Beckman Coulter Life Sciences, a prominent global player, introduces the QbD1200+ Total Organic Carbon (TOC) Analyzer. This cutting-edge instrument aims to expedite pharmaceutical and biopharmaceutical analysis processes, providing enhanced data robustness while ensuring ease of use and cost-effectiveness. Noteworthy features include streamlined validation procedures, encrypted data reporting capabilities, and compliance with crucial regulations such as 21 CFR Part 11, as well as key pharmacopeia standards like USP, EP, JP, IP, KP.

Matthieu Chausseau, the Product Manager, emphasized the company’s commitment to meeting customer demands through innovative solutions. He highlighted the QbD1200+ Laboratory TOC Analyzer’s user-friendly design, tailored to simplify TOC measurements, ensure reproducibility, and offer cost efficiency through the use of a single reagent.

Equipped with a state-of-the-art digital non-dispersive infrared sensor (NDIR) featuring auto-correct drift functionality, the analyzer guarantees long-term stability and delivers precise results. Additional benefits include control over the UV reactor temperature, dynamic endpoint detection, and minimal sample-to-sample carryover.

The instrument’s maintenance and operation are further optimized by the integration of 7 different sensors that perform automatic system checks upon startup and provide continuous monitoring throughout operation.

An innovative feature of the analyzer is the active directory, facilitating the secure export of encrypted data to a shared network directory, promoting audit trail integrity in a paperless environment, all without the need for a dedicated PC.

The intuitive user interface, coupled with a sizable color touchscreen, enhances daily usability, streamlines workflows, and reduces the necessity for extensive training, particularly in laboratory settings.

Scheduled for launch exclusively at the 2024 INTERPHEX conference in New York City on April 17, 2024, the QbD1200+ Laboratory TOC Analyzer is tailored for pharmaceutical and biopharmaceutical applications only. For further details about this innovative instrument, visit the link provided.

Insight into Beckman Coulter Life Sciences

Beckman Coulter Life Sciences, a stalwart in the scientific community, is dedicated to empowering individuals in pursuit of scientific answers. Through its comprehensive range of automation and innovation solutions catering to Centrifugation, Flow Cytometry, Genomics, Particle Analysis, and Liquid Handling workflows, the company serves as a preferred laboratory collaborator.

With a rich history dating back to 1935, Beckman Coulter Life Sciences’ technologies streamline laboratory processes, offering heightened speed, accuracy, and advanced analytics to expedite discoveries and enhance patient care. Headquartered in Indianapolis, Indiana, the company operates through 11 strategic hubs worldwide, boasting a workforce of approximately 2,800 professionals and over 400,000 systems deployed globally.